Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent
Open accessThe DOI matches its Crossref record; 82 of the 84 references it cites were found in a registry or an index.
Abstract
Idiopathic pulmonary fibrosis (IPF) is a destructive inflammatory disease with limited therapeutic options. To better understand the inflammatory responses that precede and concur with collagen deposition, we used three models of pulmonary fibrosis and identify a critical mechanistic role for IL-17A. After exposure to bleomycin (BLM), but not Schistosoma mansoni eggs, IL-17A produced by CD4+ and γδ+ T cells induced significant neutrophilia and pulmonary fibrosis. Studies conducted with C57BL/6 il17a−/− mice confirmed an essential role for IL-17A. Mechanistically, using ifnγ−/−, il10−/−, il10−/−il12p40−/−, and il10−/−il17a−/− mice and TGF-β blockade, we demonstrate that IL-17A–driven fibrosis is suppressed by IL-10 and facilitated by IFN-γ and IL-12/23p40. BLM-induced IL-17A production was also TGF-β dependent, and recombinant IL-17A–mediated fibrosis required TGF-β, suggesting cooperative roles for IL-17A and TGF-β in the development of fibrosis. Finally, we show that fibrosis induced by IL-1β, which mimics BLM-induced fibrosis, is also highly dependent on IL-17A. IL-17A and IL-1β were also increased in the bronchoalveolar lavage fluid of patients with IPF. Together, these studies identify a critical role for IL-17A in fibrosis, illustrating the potential utility of targeting IL-17A in the treatment of drug and inflammation-induced fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-17A increases and stabilizes TGF-βRII expression on fibroblasts, thereby enhancing their sensitivity to TGF-β120”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [120]
In the citing paper
“the functions of IL-17 include stimulation of ECM production, collagen disposition, and mediation of TGF-β signaling (144).”
From The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis (2018) · cites this paper as [144]
In the citing paper
“murine studies in which administration of IL-17A is sufficient to induce collagen accumulation and fibrotic lesions (144, 145)”
From The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis (2018) · cites this paper as [144]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992 · cited 6×
“More recently, studies have also suggested important inflammatory activities for TGF, with TGF providing an integral differentiation signal for the develop ment of proinflammatory IL17A–secreting cells (Bettelli et al., 2006; Veldhoen et al., 2006).”
BackgroundResultInfluentialCellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
Self-citationIL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099 · cited 5×
“These observations also suggest that IL10 inhibits the development of BLMinduced fibrosis by targeting the proinflammatory IL23–IL17A pathway rather than the IL12–IFN axis.”
BackgroundInfluentialVeldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605 · cited 3×
“However, recent studies demonstrated that TGF is also critically involved in the development of IL17A–producing lymphocytes (Bettelli et al., 2006; Veldhoen et al., 2006), which regulate the development of a variety of inflammatory and autoimmune diseases (Tesmer et al., 2008).”
BackgroundSutton, C. E., Lalor, S. J., Sweeney, C. M., Brereton, C. F., Lavelle, E. C., & Mills, K. H. G. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.001 · Cited by 1,553 · cited 3×
“Similarly, IL1 can stimulate IL17A production (Sutton et al., 2009), and IL1 is a critical mediator of pulmonary fibrosis (Gasse et al., 2007).”
BackgroundMcGeachy, M. J., Bak-Jensen, K. S., Chen, Y., Tato, C. M., Blumenschein, W., McClanahan, T., & Cua, D. J. (2007) · Nature Immunology · doi:10.1038/ni1539 · Cited by 1,520 · cited 3×
“Similar to previ ous studies (McGeachy et al., 2007; Stumhofer et al., 2007), IL10 was often coexpressed with IL17A and RoRt, sug gesting that Th17 cells may develop into IL10–secreting cells to limit Th17 effector function.”
ResultInduction and effector functions of TH17 cells
Bettelli, E., Korn, T., Oukka, M., & Kuchroo, V. K. (2008) · Nature · doi:10.1038/nature07036 · Cited by 1,216 · cited 2×
“, 2006), which regulate the pathogenesis of a variety of autoimmune and inflammatory diseases (Bettelli et al., 2008).”
BackgroundTesmer, L. A., Lundy, S. K., Sarkar, S., & Fox, D. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00628.x · Cited by 1,102
Nakae, S., Komiyama, Y., Nambu, A., Sudo, K., Iwase, M., Homma, I., Sekikawa, K., Asano, M., & Iwakura, Y. (2002) · Immunity · doi:10.1016/s1074-7613(02)00391-6 · Cited by 1,052 · cited 1×
“However, IL17A has been implicated in IL13– associated airway hyperreactivity (Nakae et al., 2002).”
BackgroundOrtiz, L. A., DuTreil, M., Fattman, C., Pandey, A. C., Torres, G., Go, K., & Phinney, D. G. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704421104 · Cited by 1,019 · cited 1×
“These observations are consistent with studies that suggested IL10 could regulate the magnitude and effec tor function of Th17 responses (Fitzgerald et al., 2007; McGeachy et al., 2007; Chang et al., 2008).”
ResultSutton, C., Brereton, C., Keogh, B., Mills, K. H. G., & Lavelle, E. C. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060285 · Cited by 1,010 · cited 2×
“These mediators included IL6, IL12/23p40, the neutrophil chemokine KC (CXCL1), and, perhaps most strikingly, IL1, which was recently impli cated in BLMinduced fibrosis (Gasse et al., 2007) and in amplifying Th17 responses (Sutton et al., 2006, 2009; Fig.”
BackgroundIshigame, H., Kakuta, S., Nagai, T., Kadoki, M., Nambu, A., Komiyama, Y., Fujikado, N., Tanahashi, Y., Akitsu, A., Kotaki, H., et al. (2009) · Immunity · doi:10.1016/j.immuni.2008.11.009 · Cited by 1,004 · cited 1×
“A comprehensive study by Ishigame et al. (2009) highlighted the overlapping but also distinct roles of IL17A and IL17F.”
BackgroundLee, C. G., Homer, R. J., Zhu, Z., Lanone, S., Wang, X., Koteliansky, V., Shipley, J. M., Gotwals, P., Noble, P., Chen, Q., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.809 · Cited by 940 · cited 3×
“Some studies found that IL13 induces and activates TGF1 (Lee et al., 2001), which then serves as the primary mediator of fi brosis by stimulating collagen synthesis in fibroblasts (Czaja et al., 1989).”
BackgroundThe Nalp3 inflammasome is essential for the development of silicosis
Cassel, S. L., Eisenbarth, S. C., Iyer, S. S., Sadler, J. J., Colegio, O. R., Tephly, L. A., Carter, A. B., Rothman, P. B., Flavell, R. A., & Sutterwala, F. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803933105 · Cited by 907 · cited 2×
“In addition, we show that IL17A is required for the development of inflammation, neutrophilia, and pulmonary fibrosis after exposure to IL1, a recently described initiator of fibrosis (Wang et al., 2000; Ortiz et al., 2007; Gasse et al., 2007; Cassel et al., 2008; Hoshino et al., 2009).”
BackgroundFichtner-Feigl, S., Strober, W., Kawakami, K., Puri, R. K., & Kitani, A. (2006) · Nature Medicine · doi:10.1038/nm1332 · Cited by 889 · cited 2×
“Unexpectedly, although small interfering RNA gene silenc ing studies implicated IL13 in the mechanism of BLM induced pulmonary fibrosis (FichtnerFeigl et al., 2006), our studies conducted with C57BL/6 il13/ and il13R2/ mice failed to reveal a significant role for IL13 signaling at this early stage of fibrosi…”
BackgroundResultNeutrophil Recruitment by Human IL-17 Via C-X-C Chemokine Release in the Airways
Laan, M., Cui, Z.-H., Hoshino, H., Lötvall, J., Sjöstrand, M., Gruenert, D. C., Skoogh, B.-E., & Lindén, A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.2347 · Cited by 880 · cited 2×
“…and to a greater extent in il10/ mice, we inves tigated whether IL12/23p40 was regulating the develop ment of IL17A–producing cells and pulmonary fibrosis. neutrophils to sites of inflammation via induction of CXC chemokines (Laan et al., 1999; Witowski et al., 2000; Miyamoto et al., 2003).”
BackgroundPulmonary fibrosis: pathogenesis, etiology and regulation
Wilson, M. S., & Wynn, T. A. (2009) · Mucosal Immunology · doi:10.1038/mi.2008.85 · Cited by 822 · cited 1×
“20092121 535 Despite distinct etiological and clinical features, most chronic fibrotic disorders have in common a persistent irritant that sustains the production of growth factors, proteolytic enzymes, angiogenic factors, and fibrogenic cytokines (Wilson and Wynn, 2009).”
BackgroundSelf-citationInterleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10
Stumhofer, J. S., Silver, J. S., Laurence, A., Porrett, P. M., Harris, T. H., Turka, L. A., Ernst, M., Saris, C. J. M., O'Shea, J. J., & Hunter, C. A. (2007) · Nature Immunology · doi:10.1038/ni1537 · Cited by 775 · cited 2×
“Similar to previ ous studies (McGeachy et al., 2007; Stumhofer et al., 2007), IL10 was often coexpressed with IL17A and RoRt, sug gesting that Th17 cells may develop into IL10–secreting cells to limit Th17 effector function.”
ResultRegulation of inflammatory responses by IL-17F
Yang, X. O., Chang, S. H., Park, H., Nurieva, R., Shah, B., Acero, L., Wang, Y.-H., Schluns, K. S., Broaddus, R. R., Zhu, Z., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071978 · Cited by 739 · cited 2×
“Functionally, IL17F and IL17A also appear to have opposing roles in the allergic lung, with IL17F negatively regulating and IL17A positively regulating Th2 mediated inflammation (Yang et al., 2008).”
BackgroundChiaramonte, M. G., Donaldson, D. D., Cheever, A. W., & Wynn, T. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7325 · Cited by 603 · cited 8×
“2, B and E), thus contrasting with the S. mansoni egg–induced fibrosis, which is highly dependent on IL4 and IL13 (Chiaramonte et al., 1999).”
BackgroundResultInfluentialSelf-citationJankovic, D., Kullberg, M. C., Feng, C. G., Goldszmid, R. S., Collazo, C. M., Wilson, M., Wynn, T. A., Kamanaka, M., Flavell, R. A., & Sher, A. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062175 · Cited by 594 · cited 2×
“, 2007) and similar to IFN and IL10 coexpressing cells (Anderson et al., 2007; Jankovic et al., 2007; Saraiva et al., 2009).”
ResultSelf-citationAnderson, C. F., Oukka, M., Kuchroo, V. J., & Sacks, D. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061886 · Cited by 571 · cited 1×
“IL17A mRNA tran scripts were also upregulated in CD4+IL10+ cells, suggest ing coexpression of IL17A and IL10, as previously reported (McGeachy et al., 2007; Stumhofer et al., 2007) and similar to IFN and IL10 coexpressing cells (Anderson et al., 2007; Jankovic et al., 2007; Saraiva et al., 2009).”
ResultMa, H.-L., Liang, S., Li, J., Napierata, L., Brown, T., Benoit, S., Senices, M., Gill, D., Dunussi-Joannopoulos, K., Collins, M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33263 · Cited by 544
Fitzgerald, D. C., Zhang, G.-X., El-Behi, M., Fonseca-Kelly, Z., Li, H., Yu, S., Saris, C. J. M., Gran, B., Ciric, B., & Rostami, A. (2007) · Nature Immunology · doi:10.1038/ni1540 · Cited by 529 · cited 1×
“These observations are consistent with studies that suggested IL10 could regulate the magnitude and effec tor function of Th17 responses (Fitzgerald et al., 2007; McGeachy et al., 2007; Chang et al., 2008).”
ResultGasse, P., Mary, C., Guenon, I., Noulin, N., Charron, S., Schnyder-Candrian, S., Schnyder, B., Akira, S., Quesniaux, V. F. J., Lagente, V., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32285 · Cited by 481 · cited 8×
“These mediators included IL6, IL12/23p40, the neutrophil chemokine KC (CXCL1), and, perhaps most strikingly, IL1, which was recently impli cated in BLMinduced fibrosis (Gasse et al., 2007) and in amplifying Th17 responses (Sutton et al., 2006, 2009; Fig.”
BackgroundMethodResultInfluentialKryczek, I., Bruce, A. T., Gudjonsson, J. E., Johnston, A., Aphale, A., Vatan, L., Szeliga, W., Wang, Y., Liu, Y., Welling, T. H., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4733 · Cited by 470 · cited 2×
“2 E), suggesting that the IL12–IFN axis may be involved in the recruitment of IL23–dependent IL17A– producing cells into the lung, as previously re ported (Kryczek et al., 2008).”
Leppkes, M., Becker, C., Ivanov, I. I., Hirth, S., Wirtz, S., Neufert, C., Pouly, S., Murphy, A. J., Valenzuela, D. M., Yancopoulos, G. D., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.018 · Cited by 444 · cited 3×
“…mice were provided by R. Flavell (Yale University, New Haven, CT; Kamanaka et al., 2006). il17a/ animals were generated and provided by Regeneron (Leppkes et al., 2009). il10/il17a/ animals were generated by crossing il10/ with il17a/, with gene expression and protein production confirmed by PCR…”
MethodIn vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis.
Czaja, M. J., Weiner, F. R., Flanders, K. C., Giambrone, M. A., Wind, R., Biempica, L., & Zern, M. A. (1989) · The Journal of cell biology · doi:10.1083/jcb.108.6.2477 · Cited by 415 · cited 2×
“Some studies found that IL13 induces and activates TGF1 (Lee et al., 2001), which then serves as the primary mediator of fi brosis by stimulating collagen synthesis in fibroblasts (Czaja et al., 1989).”
BackgroundEid, R. E., Rao, D. A., Zhou, J., Lo, S.-F. L., Ranjbaran, H., Gallo, A., Sokol, S. I., Pfau, S., Pober, J. S., & Tellides, G. (2009) · Circulation · doi:10.1161/circulationaha.108.827618 · Cited by 412 · cited 2×
“It is interesting to note that IL17A and IFN synergistically promote chemokine re sponses in a variety of inflamed tissues (Albanesi et al., 1999; Andoh et al., 2001; Eid et al., 2009), suggesting a coordinated response between IL17A and IFN.”
BackgroundMeltzer, E. B., & Noble, P. W. (2008) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-3-8 · Cited by 407
Kamanaka, M., Kim, S. T., Wan, Y. Y., Sutterwala, F. S., Lara-Tejero, M., Galán, J. E., Harhaj, E., & Flavell, R. A. (2006) · Immunity · doi:10.1016/j.immuni.2006.09.013 · Cited by 390 · cited 2×
“IL10gfp reporter mice were provided by R. Flavell (Yale University, New Haven, CT; Kamanaka et al., 2006). il17a/ animals were generated and provided by Regeneron (Leppkes et al., 2009). il10/il17a/ animals were generated by crossing il10/ with il17a/, with gene expression and protein production…”
MethodMechanisms of bleomycin-induced lung damage
Hay, J., Shahzeidi, S., & Laurent, G. (1991) · Archives of Toxicology · doi:10.1007/bf02034932 · Cited by 389 · cited 3×
“, 2009), whereas BLM induces rapid epithelial cell death and destruction of DNA (Hay et al., 1991), leading to acute proinflammatory Th1/Th17type cytokine production.”
BackgroundInfluentialIL-13 Activates a Mechanism of Tissue Fibrosis That Is Completely TGF-β Independent
Kaviratne, M., Hesse, M., Leusink, M., Cheever, A. W., Davies, S. J., McKerrow, J. H., Wakefield, L. M., Letterio, J. J., & Wynn, T. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.4020 · Cited by 370 · cited 11×
“Nevertheless, other studies demonstrated that IL13 could function independently of TGF1 (Kaviratne et al., 2004).”
BackgroundInfluentialSelf-citationAlbanesi, C., Cavani, A., & Girolomoni, G. (1999) · PubMed · Cited by 355
The IL-21 receptor augments Th2 effector function and alternative macrophage activation
Pesce, J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27727 · Cited by 346
Omega-1, a glycoprotein secreted by Schistosoma mansoni eggs, drives Th2 responses
Everts, B., Perona-Wright, G., Smits, H. H., Hokke, C. H., van der Ham, A. J., Fitzsimmons, C. M., Doenhoff, M. J., van der Bosch, J., Mohrs, K., Haas, H., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082460 · Cited by 330 · cited 1×
“S. mansoni eggs are also highly immunogenic, inducing robust antigenspecific CD4+ Th2 responses (Everts et al., 2009; Steinfelder et al., 2009), whereas BLM induces rapid epithelial cell death and destruction of DNA (Hay et al., 1991), leading to acute proinflammatory Th1/Th17type cytokine…”
BackgroundSchwarzenberger, P., La Russa, V., Miller, A., Ye, P., Huang, W., Zieske, A., Nelson, S., Bagby, G. J., Stoltz, D., Mynatt, R. L., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.6383 · Cited by 325 · cited 1×
“IL17A can directly induce the collagenase MMP1 (Cortez et al., 2007) and progelatinase, MMP3 (Beklen et al., 2007) from various fibroblasts, suggesting that IL17A may facilitate tissue disruption, in addition to its abil ity to promote granulopoiesis (Schwarzenberger et al., 1998) and inflammation.”
BackgroundSaraiva, M., Christensen, J. R., Veldhoen, M., Murphy, T. L., Murphy, K. M., & O'Garra, A. (2009) · Immunity · doi:10.1016/j.immuni.2009.05.012 · Cited by 315 · cited 1×
“IL17A mRNA tran scripts were also upregulated in CD4+IL10+ cells, suggest ing coexpression of IL17A and IL10, as previously reported (McGeachy et al., 2007; Stumhofer et al., 2007) and similar to IFN and IL10 coexpressing cells (Anderson et al., 2007; Jankovic et al., 2007; Saraiva et al., 2009).”
ResultAlbanesi, C., Cavani, A., & Girolomoni, G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.1.494 · Cited by 307 · cited 2×
“It is interesting to note that IL17A and IFN synergistically promote chemokine re sponses in a variety of inflamed tissues (Albanesi et al., 1999; Andoh et al., 2001; Eid et al., 2009), suggesting a coordinated response between IL17A and IFN.”
BackgroundWitowski, J., Pawlaczyk, K., Breborowicz, A., Scheuren, A., Kuzlan-Pawlaczyk, M., Wisniewska, J., Polubinska, A., Friess, H., Gahl, G. M., Frei, U., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5814 · Cited by 305 · cited 2×
“…and to a greater extent in il10/ mice, we inves tigated whether IL12/23p40 was regulating the develop ment of IL17A–producing cells and pulmonary fibrosis. neutrophils to sites of inflammation via induction of CXC chemokines (Laan et al., 1999; Witowski et al., 2000; Miyamoto et al., 2003).”
BackgroundBaseline BAL Neutrophilia Predicts Early Mortality in Idiopathic Pulmonary Fibrosis
Kinder, B. W., Brown, K. K., Schwarz, M. I., Ix, J. H., Kervitsky, A., & King, T. E. (2008) · Chest · doi:10.1378/chest.07-1948 · Cited by 302 · cited 17×
“, 2008), with airway neutrophilia identified as a predictor of early mortality in IPF (Kinder et al., 2008).”
BackgroundInfluentialSteinfelder, S., Andersen, J. F., Cannons, J. L., Feng, C. G., Joshi, M., Dwyer, D., Caspar, P., Schwartzberg, P. L., Sher, A., & Jankovic, D. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082462 · Cited by 294 · cited 1×
“S. mansoni eggs are also highly immunogenic, inducing robust antigenspecific CD4+ Th2 responses (Everts et al., 2009; Steinfelder et al., 2009), whereas BLM induces rapid epithelial cell death and destruction of DNA (Hay et al., 1991), leading to acute proinflammatory Th1/Th17type cytokine…”
BackgroundLin, Y., Ritchea, S., Logar, A., Slight, S., Messmer, M., Rangel-Moreno, J., Guglani, L., Alcorn, J. F., Strawbridge, H., Park, S. M., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.025 · Cited by 289 · cited 1×
“…in il10/il17a/ mice compared with il10/ mice, suggesting that IL17A may facilitate the recruit ment of IFN–producing cells via lymphocyterecruiting chemokines (Zrioual et al., 2008), cell survival (Sergejeva et al., 2005), or direct induction of IL12 and IFN by mac rophages (Lin et al., 2009).”
BackgroundMiyamoto, M., Prause, O., Sjöstrand, M., Laan, M., Lötvall, J., & Lindén, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.9.4665 · Cited by 281
Kitani, A., Fuss, I., Nakamura, K., Kumaki, F., Usui, T., & Strober, W. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030917 · Cited by 260 · cited 1×
“IL-10 limits IL-17A/IFN- production and pulmonary fibrosis Exogenous IL10 treatment suppresses BLMinduced fibrosis (Arai et al., 2000; Kitani et al., 2003; Kradin et al., 2004; Nakagome et al., 2006); however, the mechanism of action and role of endogenous IL10 remains much less clear.”
BackgroundMMPs, IL-1, and TNF are Regulated by IL-17 in Periodontitis
Beklen, A., Ainola, M., Hukkanen, M., Gürgan, C., Sorsa, T., & Konttinen, Y. T. (2007) · Journal of Dental Research · doi:10.1177/154405910708600409 · Cited by 259 · cited 4×
“Inter estingly, the reduced inflammation and fibrosis observed in BLMtreated il17a/ animals was associated with reduced IL1 expression, suggesting that IL17A promotes IL1 production, as has been observed in vitro with cultured fibro blasts (Beklen et al., 2007).”
BackgroundInfluentialNeutrophils, interleukin-17A and lung disease
Lindén, A., Laan, M., & Anderson, G. P. (2005) · European Respiratory Journal · doi:10.1183/09031936.04.00032904 · Cited by 252 · cited 2×
“Interestingly, it is now well appreciated that IL17A is involved in the recruitment of neutrophils to sites of inflammation via induction of IL8 and CXC chemo kines, including MIP2 (Laan et al., 1999; Witowski et al., 2000; Miyamoto et al., 2003; Lindén et al., 2005).”
BackgroundWang, R., Ibarra-Sunga, O., Verlinski, L., Pick, R., & Uhal, B. D. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.1.l143 · Cited by 245 · cited 4×
“Indeed, administration of IL1 alone mimics much of the pulmonary pathology caused by BLM (Wang et al., 2000; Gasse et al., 2007; Ortiz et al., 2007; Hoshino et al., 2009).”
BackgroundInfluentialCortez, D. M., Feldman, M. D., Mummidi, S., Valente, A. J., Steffensen, B., Vincenti, M., Barnes, J. L., & Chandrasekar, B. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00928.2007 · Cited by 241 · cited 1×
“IL17A can directly induce the collagenase MMP1 (Cortez et al., 2007) and progelatinase, MMP3 (Beklen et al., 2007) from various fibroblasts, suggesting that IL17A may facilitate tissue disruption, in addition to its abil ity to promote granulopoiesis (Schwarzenberger et al., 1998) and inflammation.”
BackgroundMechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis.
Hunninghake, G. W., Gadek, J. E., Lawley, T. J., & Crystal, R. G. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110242 · Cited by 239 · cited 4×
“Indeed neutrophilia is a com mon feature of fibrosis and pulmonary alveolitis in IPF patients (Hunninghake et al., 1981; Kinder et al., 2008), with airway neutrophilia identified as a predictor of early mortality in IPF (Kinder et al.”
BackgroundInfluentialHata, K., Andoh, A., Shimada, M., Fujino, S., Bamba, S., Araki, Y., Okuno, T., Fujiyama, Y., & Bamba, T. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00494.2001 · Cited by 218 · cited 1×
“…of inflammation and pulmonary fibrosis, IL17A can stimulate IL6, IL8, and MCP1 from bronchial epithelial cells (Laan et al., 2001) or fibroblasts (Hata et al., 2002; Mahanonda et al., 2008) and, as mentioned in the previous paragraph, is inducible by IL1 and IL23, placing IL17A in a central 548…”
BackgroundLaan, M., Lötvall, J., Chung, K. F., & Lindén, A. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704063 · Cited by 193 · cited 2×
“In the context of inflammation and pulmonary fibrosis, IL17A can stimulate IL6, IL8, and MCP1 from bronchial epithelial cells (Laan et al., 2001) or fibroblasts (Hata et al.”
BackgroundSergejeva, S., Ivanov, S., Lötvall, J., & Lindén, A. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2004-0213oc · Cited by 184 · cited 1×
“…in il10/il17a/ mice compared with il10/ mice, suggesting that IL17A may facilitate the recruit ment of IFN–producing cells via lymphocyterecruiting chemokines (Zrioual et al., 2008), cell survival (Sergejeva et al., 2005), or direct induction of IL12 and IFN by mac rophages (Lin et al., 2009).”
BackgroundRamalingam, T. R., Pesce, J. T., Sheikh, F., Cheever, A. W., Mentink-Kane, M. M., Wilson, M. S., Stevens, S., Valenzuela, D. M., Murphy, A. J., Yancopoulos, G. D., et al. (2008) · Nature Immunology · doi:10.1038/ni1544 · Cited by 183
Self-citationCutroneo, K. R., White, S. L., Phan, S. H., & Ehrlich, H. P. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.20972 · Cited by 170 · cited 4×
“IL-17A–dependent pulmonary fibrosis requires TGF- Many studies have identified a profibrotic role for TGF, particularly in the pathogenesis of pulmonary fibrosis (Cutroneo et al., 2007).”
BackgroundInfluentialHoshino, T., Okamoto, M., Sakazaki, Y., Kato, S., Young, H. A., & Aizawa, H. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0182oc · Cited by 163 · cited 7×
“Indeed, administration of IL1 alone mimics much of the pulmonary pathology caused by BLM (Wang et al., 2000; Gasse et al., 2007; Ortiz et al., 2007; Hoshino et al., 2009).”
BackgroundInfluentialNakagome, K. (2006) · Thorax · doi:10.1136/thx.2005.056317 · Cited by 159 · cited 3×
“IL-10 limits IL-17A/IFN- production and pulmonary fibrosis Exogenous IL10 treatment suppresses BLMinduced fibrosis (Arai et al., 2000; Kitani et al., 2003; Kradin et al., 2004; Nakagome et al., 2006); however, the mechanism of action and role of endogenous IL10 remains much less clear.”
BackgroundTherapeutic Attenuation of Pulmonary Fibrosis Via Targeting of IL-4- and IL-13-Responsive Cells
Jakubzick, C., Choi, E. S., Joshi, B. H., Keane, M. P., Kunkel, S. L., Puri, R. K., & Hogaboam, C. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.5.2684 · Cited by 157 · cited 15×
“Neverthe less, a direct link between IL17A, neutrophilia, and IPF has not been previously investigated.”
BackgroundInfluentialTherapeutic Effect of IL-13 Immunoneutralization During Chronic Experimental Fungal Asthma
Blease, K., Jakubzick, C., Westwick, J. K., Lukacs, N. W., Kunkel, S. L., & Hogaboam, C. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.8.5219 · Cited by 148 · cited 2×
“Since then, IL13 has been shown to exhibit fibrotic activity in a variety of diseases and tissues, including models of chronic asthma (Blease et al., 2001), skin fibrosis (Aliprantis et al.”
BackgroundBraun, R. K., Ferrick, C., Neubauer, P. D., Sjoding, M. W., Sterner‐Kock, A., Kock, M., Putney, L. F., Ferrick, D. A., Hyde, D. M., & Love, R. B. (2008) · Inflammation · doi:10.1007/s10753-008-9062-6 · Cited by 145 · cited 1×
“One previous study suggested that IL17A producing + T cells regulate cellular recruitment with + T cell–deficient mice develop ing increased inflammation and collagen deposition (Braun et al., 2008).”
BackgroundIntroduction of the interleukin-10 gene into mice inhibited bleomycin-induced lung injury in vivo
Arai, T., Abe, K., Matsuoka, H., Yoshida, M., Mori, M., Goya, S., Kida, H., Nishino, K., Osaki, T., Tachibana, I., et al. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.278.5.l914 · Cited by 141 · cited 1×
“IL-10 limits IL-17A/IFN- production and pulmonary fibrosis Exogenous IL10 treatment suppresses BLMinduced fibrosis (Arai et al., 2000; Kitani et al., 2003; Kradin et al., 2004; Nakagome et al., 2006); however, the mechanism of action and role of endogenous IL10 remains much less clear.”
BackgroundWilson, M. S., Elnekave, E., Mentink-Kane, M. M., Hodges, M. G., Pesce, J. T., Ramalingam, T. R., Thompson, R. W., Kamanaka, M., Flavell, R. A., Keane-Myers, A., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31546 · Cited by 137
Self-citationZrioual, S., Toh, M.-L., Tournadre, A., Zhou, Y., Cazalis, M.-A., Pachot, A., Miossec, V., & Miossec, P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.1.655 · Cited by 137 · cited 2×
“6 G) were sig nificantly reduced in il10/il17a/ mice compared with il10/ mice, suggesting that IL17A may facilitate the recruit ment of IFN–producing cells via lymphocyterecruiting chemokines (Zrioual et al., 2008), cell survival (Sergejeva et al.”
BackgroundAliprantis, A. O., Wang, J., Fathman, J. W., Lemaire, R., Dorfman, D. M., Lafyatis, R., & Glimcher, L. H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700021104 · Cited by 134 · cited 2×
“Since then, IL13 has been shown to exhibit fibrotic activity in a variety of diseases and tissues, including models of chronic asthma (Blease et al., 2001), skin fibrosis (Aliprantis et al., 2007), and bronchiolitis obliterans (Keane et al., 2007).”
BackgroundChen, E. S., Greenlee, B. M., Wills-Karp, M. A., & Möller, D. R. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.24.5.4064 · Cited by 132 · cited 4×
“Previous studies identified a role for IFN in BLM induced fibrosis (Chen et al., 2001), which was consistent with our findings.”
BackgroundResultInfluentialWhittington (2004) · doi:10.1165/rcmb.2003-0285oc · Cited by 130 · cited 4×
“In contrast, S. mansoni IPF, 14.31 ± 3.76 pg/ml) and IL1 (NV, 9.58 ± 1.58 pg/ml; IPF, 21.36 ± 3.97 pg/ml), but not IL22 (NV, 56.1 ± 2.00 pg/ml; IPF, 50.7 ± 1.47 pg/ml; Whittington et al., 2004), in BAL fluid of IPF patients were increased (Fig.”
BackgroundInfluentialVarga, J., & Pasche, B. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32830e48e8 · Cited by 107 · cited 3×
“Most studies of BLMinduced fibrosis have focused on the hypothesis that TGF regulates the development of pul monary fibrosis by directly promoting the differentiation and activation of collagenproducing myofibroblasts (Varga and Pasche, 2008).”
BackgroundA Profibrotic Function of IL-12p40 in Experimental Pulmonary Fibrosis
Huaux, F., Arras, M., Tomasi, D., Barbarin, V., Delos, M., Coutelier, J., Vink, A., Phan, S. H., Renauld, J., & Lison, D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2653 · Cited by 97 · cited 1×
“5 C), which is consistent with related studies (Maeyama et al., 2001; Huaux et al., 2002; Sakamoto et al., 2002).”
ResultIL-13 Is Pivotal in the Fibro-Obliterative Process of Bronchiolitis Obliterans Syndrome
Keane, M. P., Gomperts, B. N., Weigt, S., Xue, Y., Burdick, M. D., Nakamura, H. K., Zisman, D. A., Ardehali, A. A., Saggar, R., Lynch, J. P., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.511 · Cited by 88 · cited 2×
“, 2007), and bronchiolitis obliterans (Keane et al., 2007).”
BackgroundGalbraith, G. M. P. (2009) · Yearbook of Dermatology and Dermatologic Surgery · doi:10.1016/s0093-3619(08)79230-x · Cited by 83
Timp-1 is a Key Factor of Fibrogenic Response to Bleomycin in Mouse Lung
Manoury, B., Caulet-Maugendre, S., Guénon, I., Lagente, V., & Boichot, E. (2006) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200601900303 · Cited by 77 · cited 2×
“The peak in fibrosis was preceded by marked increases in matrix metalloproteinase (MMP) 12, tissue inhibitor of MMP (TIMP) 1 (Manoury et al., 2006), and COL3 messenger RNA (mRNA) expression (Fig.”
BackgroundIL‐10 interferes directly with TCR‐induced IFN‐γ but not IL‐17 production in memory T cells
Naundorf, S., Schröder, M., Höflich, C., Suman, N., Volk, H., & Grütz, G. (2009) · European Journal of Immunology · doi:10.1002/eji.200838773 · Cited by 76 · cited 1×
“4 B), which was consistent with the increased levels observed in patients 538 IL-17A–mediated pulmonary fibrosis | Wilson et al. is consistent with a recent study examining the in vitro dif ferentiation of human Th17 cells (Naundorf et al., 2009).”
ResultAndoh, A., Takaya, H., Makino, J., Sato, H., Bamba, S., Araki, Y., Hata, K., Shimada, M., Okuno, T., Fujiyama, Y., et al. (2001) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2001.01588.x · Cited by 58 · cited 2×
“It is interesting to note that IL17A and IFN synergistically promote chemokine re sponses in a variety of inflamed tissues (Albanesi et al., 1999; Andoh et al., 2001; Eid et al., 2009), suggesting a coordinated response between IL17A and IFN.”
BackgroundAttenuation of bleomycin-induced pneumopathy in mice by monoclonal antibody to interleukin-12
Maeyama, T., Kuwano, K., Kawasaki, M., Kunitake, R., Hagimoto, N., & Hara, N. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.280.6.l1128 · Cited by 55 · cited 1×
“5 C), which is consistent with related studies (Maeyama et al., 2001; Huaux et al., 2002; Sakamoto et al., 2002).”
ResultChang, H., Hanawa, H., Yoshida, T., Hayashi, M., Liu, H., Ding, L., Otaki, K., Hao, K., Yoshida, K., Kato, K., et al. (2008) · Circulation Journal · doi:10.1253/circj.72.813 · Cited by 55
Sakamoto, H., Zhao, L.-H., Jain, F. A., & Kradin, R. L. (2002) · Experimental and Molecular Pathology · doi:10.1006/exmp.2001.2409 · Cited by 44 · cited 1×
“5 C), which is consistent with related studies (Maeyama et al., 2001; Huaux et al., 2002; Sakamoto et al., 2002).”
ResultIL-10 inhibits inflammation but does not affect fibrosis in the pulmonary response to bleomycin
Kradin, R. L., Sakamoto, H., Jain, F. A., Zhao, L.-H., Hymowitz, G., & Preffer, F. I. (2004) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2003.12.010 · Cited by 41 · cited 4×
“IL-10 limits IL-17A/IFN- production and pulmonary fibrosis Exogenous IL10 treatment suppresses BLMinduced fibrosis (Arai et al., 2000; Kitani et al., 2003; Kradin et al., 2004; Nakagome et al., 2006); however, the mechanism of action and role of endogenous IL10 remains much less clear.”
BackgroundInfluentialEffects of IL-17 on Human Gingival Fibroblasts
Mahanonda, R., Jitprasertwong, P., Sa‐Ard‐Iam, N., Rerkyen, P., Charatkulangkun, O., Jansisyanont, P., Nisapakultorn, K., Yongvanitchit, K., & Pichyangkul, S. (2008) · Journal of Dental Research · doi:10.1177/154405910808700314 · Cited by 33 · cited 1×
“…pulmonary fibrosis, IL17A can stimulate IL6, IL8, and MCP1 from bronchial epithelial cells (Laan et al., 2001) or fibroblasts (Hata et al., 2002; Mahanonda et al., 2008) and, as mentioned in the previous paragraph, is inducible by IL1 and IL23, placing IL17A in a central 548 IL-17A–mediated…”
BackgroundImpairment of Alveolar Macrophage Transcription in Idiopathic Pulmonary Fibrosis
Ren, P., Rosas, I. O., MacDonald, S. D., Wu, H.-P., Billings, E. M., & Gochuico, B. R. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200607-958oc · Cited by 26 · cited 2×
“Bronchoscopy with BAL was performed as previ ously described (Ren et al., 2007).”
MethodSelf-citationA critical assessment of treatment options for idiopathic pulmonary fibrosis.
Shah, N. R., Noble, P. W., Jackson, R. M., King, T. E., Nathan, S. D., Padilla, M. L., Raghu, G., Rhodes, M. B., Schwarz, M. I., Tino, G., et al. (2005) · PubMed · Cited by 23
Uebelhoer, M., Bewig, B., Oldigs, M., Nowak, F. D., Magnussen, F. H., Petermann, F. W., & Barth, J. (1993) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365519309092562 · Cited by 7 · cited 1×
“However, unlike chronic liver fibrosis, hydroxyproline assays and Masson’s trichrome staining of lung tissue suggested that JEM VOL. 207, March 15, 2010 Article 537 with pulmonary fibrotic diseases (Uebelhoer et al., 1993).”
BackgroundA critical assessment of treatment options for idiopathic pulmonary fibrosis
Shah, N. R., Noble, P. W., & Dubois, R. W. (2004) · CHEST Journal · doi:10.1016/s0012-3692(16)46920-5 · Cited by 2
Cited by
Protective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269
“IL-1β stimulates T H 17 cells to produce IL-17, which was identified as an important inducer of bleomycin-induced pulmonary fibrosis, a fibrotic disorder with characteristics that are similar to those of IP”
BackgroundSelf-citationMechanisms of fibrosis: therapeutic translation for fibrotic disease
Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541
Self-citationFibrosis: from mechanisms to medicines
Henderson, N. C., Rieder, F., & Wynn, T. A. (2020) · Nature · doi:10.1038/s41586-020-2938-9 · Cited by 1,868
Self-citationTargeting IL-17 and TH17 cells in chronic inflammation
Miossec, P., & Kolls, J. K. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3794 · Cited by 1,414
Macrophages: master regulators of inflammation and fibrosis
Wynn, T., & Barron, L. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1255354 · Cited by 1,392
Self-citation
Metadata
- Authors
- Wilson, M. S., Madala, S. K., Ramalingam, T. R., Gochuico, B. R., Rosas, I. O., Cheever, A. W., & Wynn, T. A.
- Affiliations
- National Institutes of Health (US)
- Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115 3
- Biomedical Research Institute (US)
- Corresponding author
- Wynn, Thomas A.
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2010-02-22
- Volume
- 207
- Issue
- 3
- Pages
- 535-552
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2839145
- OpenAlex
- W2095715691
- Cited by
- 730
- References
- 84
- Citations by year
- 2026: 28 · 2025: 39 · 2024: 68 · 2023: 45 · 2022: 47 · 2021: 39 · 2020: 38 · 2019: 51 · 2018: 47 · 2017: 48 · 2016: 42 · 2015: 42 · 2014: 40 · 2013: 57 · 2012: 45
- FWCI
- 41.61
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Keywords
- idiopathic pulmonary fibrosis, IL-17A, bleomycin-induced lung injury, IL-1β, pulmonary fibrosis, TGF-beta, IL-10, interferon-gamma, IL-12/23p40, γδ T cells, CD4+ T cells, neutrophilia, Schistosoma mansoni eggs, bronchoalveolar lavage, IL-17A blockade
- MeSH terms
- Animals, Bleomycin, Interferon-gamma, Lung, Male, Mice, Inbred C57BL, Pulmonary Fibrosis, Schistosoma mansoni, Schistosomiasis mansoni, CD4-Positive T-Lymphocytes, Interleukin-10, Mice, Knockout, Interleukin-13, Interleukin-17, Mice, Interleukin-1beta, Interleukin-12 Subunit p40
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.